Can-Fite BioPharma Ltd. ( CANF) - Key Metrics
CANF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | $0 | -$0.01 | -$0.01 | -$0.01 |
| 2025Q3 | $0 | -$0.01 | -$0.01 | -$0.01 |
| 2025Q2 | $0 | $0 | $0 | $0 |
| 2025Q1 | $0 | $0 | $0 | $0 |
| 2024Q4 | $0 | $0 | $0 | $0 |
CANF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | 0% | -131.58 |
| 2025Q3 | 0% | -407.89 |
| 2025Q2 | 0% | -3750 |
| 2025Q1 | 0% | -5285.71 |
| 2024Q4 | 0% | -5093.75 |
CANF
Price: $2.27
52 week price:
Earnings Per Share: -10.75 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: Israel
Volume: 29900
Market Capitalization: 4.8 million